Neurodevelopmental problems at 18 months among children exposed to paracetamol in utero: a propensity score matched

Richelle Vlenterie1,2, Mollie E Wood2, Ragnhild Eek Brandlistuen1,2

  • 1Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Insights

Long-term prenatal paracetamol use is linked to neurodevelopmental issues like delayed motor skills and communication problems in children. Short-term use showed no increased risks, suggesting caution with prolonged exposure during pregnancy.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Pharmacoepidemiology

Background:

  • Prenatal exposure to paracetamol (acetaminophen) may increase neurodevelopmental problem risks in children.
  • Paracetamol is widely used during pregnancy, making even small risk increases a public health concern.

Purpose of the Study:

  • To investigate the association between prenatal paracetamol exposure and neurodevelopmental problems in infants.
  • To differentiate risks associated with short-term versus long-term paracetamol use during gestation.

Main Methods:

  • Utilized data from the Norwegian Mother and Child Cohort Study (N=51,200 pregnancies).
  • Applied propensity score (PS) matching to analyze paracetamol exposure (short-term <28 days; long-term ≥28 days) and neurodevelopmental outcomes at 18 months.
  • Conducted sensitivity analyses to assess confounding by indication.

Main Results:

  • Long-term prenatal paracetamol exposure was associated with increased odds of communication problems (OR: 1.38, 95% CI 0.98-1.95) and delayed motor milestones (OR: 1.35, 95% CI 1.07-1.70).
  • No significant risks were observed for short-term paracetamol exposure.
  • Sensitivity analyses supported the PS-matched findings, indicating minimal confounding by indication.

Conclusions:

  • Prolonged in utero exposure to paracetamol is linked to modest increases in motor and communication delays at 18 months.
  • Caution is advised regarding long-term paracetamol use in pregnancy.
  • Women with severe pain conditions require appropriate pharmacotherapy, even during pregnancy.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
636
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
840